HBV-IN-39-d3

CAT: 0804-HY-156703SSize: 1 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0804-HY-156703SSize:1 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

HBV-IN-39-d3 (Example 14) is a deuterated HBV-IN-39 (Example 13) . HBV-IN-39 is an HBV inhibitor. HBV-IN-39-d3 has better oral bioavailability than HBV-IN-39[1].

CAS Number

2173356-23-3

UNSPSC

12352005

Target

HBV

Type

Isotope-Labeled Compounds

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Infection

Solubility

10 mM in DMSO

Smiles

FC1=C2C3=CC(OC([2H])([2H])[2H])=C(OCCCOC)C=C3C[C@H](N2C=C(C1=O)C(O)=O)C(C)(C)C

Molecular Formula

C23H25D3FNO6

Molecular Weight

436.49

References & Citations

[1]Yi Chen, et al. Therapeutic agents for the treatment of HBV infection. Patent CN110240596B.

Shipping Conditions

Room temperature

Scientific Category

Isotope-Labeled Compounds

Clinical Information

No Development Reported

Related Products

Catalog	Name
HY-163587	PRMT5-IN-39-d3
HY-P4044	HBV Seq2 aa:28-39
HY-146395	HBV-IN-23
HY-149435	HBV-IN-36
HY-144047	HBV-IN-16
HY-149815	HBV-IN-33
HY-148780	HBV-IN-29
HY-146394	HBV-IN-22
HY-148781	HBV-IN-30
HY-145050	HBV-IN-7

Alternative Products

Catalog	Name
T76529-01	HBV Seq2 aa:28-39
ant-150	HBV
P525235	HBV-C Protein (C-His, HBV)
LV1601	HBV(+) and HBV(-) noncancerous liver tissue array
BA1849-10	HBV-IN-37
601090020	Truenat™ HBV
FSD89784-01	HBV-IN-4
T209597-01	HBV-IN-45
T89131-01	HBV-IN-47
T63795-01	HBV-IN-6

HBV-IN-39-d3

Related Products

Alternative Products

Popular Products